Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 300 results found. Search for [ Drug patent ]

Results 1 to 21 of 300
PB Jayakumar
New Delhi, October 29, 2018
A big transformation is happening in the global generic pharmaceutical industry. As a result, stocks of most major drug companies have done badly in the past one year.


BusinessToday.In
October 15, 2018
The Natco Pharma stock closed 5.57% or 37 points higher at 717.05 on the BSE. The stock has been gaining for the last two days and has risen 8.36% during the period. The stock hit an intra day high of 733.70 (8.02%) in trade today.


PTI
October 15, 2018



BusinessToday.In
July 16, 2018
The Dr Reddy's stock fell up to 10.61% or 246 points to 2,071.50 level. The stock closed 9.85% or 228 points lower at 2089.15 on the BSE.


E Kumar Sharma
New Delhi, June 19, 2018
It wants to focus on India and other emerging markets, while at some stage, perhaps sometime in 2019, it may also look at a foray into the US market. It already has an office in Boston and is scouting for a partner in the US.


PTI
May 25, 2018



PTI
May 17, 2018



Joe C Mathew
New Delhi, May 4, 2018
Chinese Ambassador to India Luo Zhaohui's recent tweet on his country's decision to remove import duties on 28 medicines, including all cancer drugs, has created flutters in India.


P.B. Jayakumar
New Delhi, April 30, 2018
Drug companies are moving up the value chain, transforming into complex generic manufacturers with high end R&D facilities.


Joe C Mathew
New Delhi, April 24, 2018
The report, which studied the prosecution history of some grants and the claim language of all granted patents during 2009-2016, states that the grants were likely contravention of anti-evergreening provisions under section 3 of the Indian Patents Act.


PTI
April 3, 2018



Joe C Mathew
New Delhi, March 13, 2018
Close to 90 health activists, patient groups and individuals workingtowards the elimination of tuberculosis have called upon Prime MinisterNarendra Modi to make drug resistant TB (DR-TB) drugs affordable byensuring supply of generic drugs


PB Jayakumar
New Delhi, February 21, 2018
The competition to tap large molecule structured complex bio-similars or off-patent biotech drugs is heating up.


Joe C Mathew
New Delhi, February 13, 2018
US based drug makers lobby group Pharmaceutical Research and Manufacturers of America (PhRMA) has complained that the positive signals given by India


PTI
January 31, 2018



E. Kumar Sharma
New Delhi, January 10, 2018
By following the strategy of doing a few things well, V.C. Nannapaneni has helped Natco Pharma carve out a space for itself.


PTI
January 4, 2018



E Kumar Sharma
New Delhi, December 19, 2017
On December 7th, Mylan launched 'HepBest', which it called, \"the first drug approved in eight years for management of chronic Hepatitis B infection in India.\" 


PTI
December 19, 2017



P.B. Jayakumar
New Delhi, December 11, 2017
Margin erosion and regulatory hurdles are hitting Indian pharma companies hard in their biggest market.


PAGES 1 OF 15  12345